×
S&P 500   4,144.86 (+2.14%)
DOW   33,097.88 (+1.41%)
QQQ   307.81 (+2.83%)
AAPL   148.78 (+3.48%)
MSFT   271.30 (+2.03%)
FB   194.58 (+1.54%)
GOOGL   2,239.84 (+3.90%)
AMZN   2,279.79 (+2.62%)
TSLA   755.82 (+6.79%)
NVDA   187.75 (+5.18%)
BABA   93.24 (-1.31%)
NIO   16.50 (+2.93%)
AMD   102.00 (+3.29%)
CGC   4.88 (-12.07%)
MU   73.10 (+3.54%)
T   21.24 (-0.38%)
GE   78.29 (+1.66%)
F   13.58 (+3.51%)
DIS   109.24 (+3.44%)
AMC   14.39 (+17.66%)
PFE   53.63 (-0.67%)
PYPL   84.94 (+5.62%)
NFLX   194.16 (+1.44%)
S&P 500   4,144.86 (+2.14%)
DOW   33,097.88 (+1.41%)
QQQ   307.81 (+2.83%)
AAPL   148.78 (+3.48%)
MSFT   271.30 (+2.03%)
FB   194.58 (+1.54%)
GOOGL   2,239.84 (+3.90%)
AMZN   2,279.79 (+2.62%)
TSLA   755.82 (+6.79%)
NVDA   187.75 (+5.18%)
BABA   93.24 (-1.31%)
NIO   16.50 (+2.93%)
AMD   102.00 (+3.29%)
CGC   4.88 (-12.07%)
MU   73.10 (+3.54%)
T   21.24 (-0.38%)
GE   78.29 (+1.66%)
F   13.58 (+3.51%)
DIS   109.24 (+3.44%)
AMC   14.39 (+17.66%)
PFE   53.63 (-0.67%)
PYPL   84.94 (+5.62%)
NFLX   194.16 (+1.44%)
S&P 500   4,144.86 (+2.14%)
DOW   33,097.88 (+1.41%)
QQQ   307.81 (+2.83%)
AAPL   148.78 (+3.48%)
MSFT   271.30 (+2.03%)
FB   194.58 (+1.54%)
GOOGL   2,239.84 (+3.90%)
AMZN   2,279.79 (+2.62%)
TSLA   755.82 (+6.79%)
NVDA   187.75 (+5.18%)
BABA   93.24 (-1.31%)
NIO   16.50 (+2.93%)
AMD   102.00 (+3.29%)
CGC   4.88 (-12.07%)
MU   73.10 (+3.54%)
T   21.24 (-0.38%)
GE   78.29 (+1.66%)
F   13.58 (+3.51%)
DIS   109.24 (+3.44%)
AMC   14.39 (+17.66%)
PFE   53.63 (-0.67%)
PYPL   84.94 (+5.62%)
NFLX   194.16 (+1.44%)
S&P 500   4,144.86 (+2.14%)
DOW   33,097.88 (+1.41%)
QQQ   307.81 (+2.83%)
AAPL   148.78 (+3.48%)
MSFT   271.30 (+2.03%)
FB   194.58 (+1.54%)
GOOGL   2,239.84 (+3.90%)
AMZN   2,279.79 (+2.62%)
TSLA   755.82 (+6.79%)
NVDA   187.75 (+5.18%)
BABA   93.24 (-1.31%)
NIO   16.50 (+2.93%)
AMD   102.00 (+3.29%)
CGC   4.88 (-12.07%)
MU   73.10 (+3.54%)
T   21.24 (-0.38%)
GE   78.29 (+1.66%)
F   13.58 (+3.51%)
DIS   109.24 (+3.44%)
AMC   14.39 (+17.66%)
PFE   53.63 (-0.67%)
PYPL   84.94 (+5.62%)
NFLX   194.16 (+1.44%)
OTCMKTS:INLX

Intellinetics (INLX) Stock Forecast, Price & News

$5.00
0.00 (0.00%)
(As of 05/26/2022 12:00 AM ET)
Add
Compare
Today's Range
$5.00
$5.00
50-Day Range
$4.36
$6.15
52-Week Range
$4.00
$9.90
Volume
N/A
Average Volume
1,591 shs
Market Capitalization
$14.16 million
P/E Ratio
11.36
Dividend Yield
N/A
Beta
0.56
30 days | 90 days | 365 days | Advanced Chart
Receive INLX News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellinetics and its competitors with MarketBeat's FREE daily newsletter.

Intellinetics logo

About Intellinetics

Intellinetics, Inc. designs, develops, tests, markets, and licenses document services and software solutions in the United States. The company operates in two segments, Document Management and Document Conversion. Its software platform allows its customers to capture and manage documents across operations, such as scanned hard-copy documents and digital documents, including Microsoft Office 365, digital images, audios, videos, and emails. The company's flagship software suite includes IntelliCloud platform that comprises image processing modules, records management, workflow, and extended components. It also provides installation, integration, training, and consulting services; ongoing software maintenance and customer support services; and digital scanning, microfilm and microfiche, box storage, scanning equipment, and software and repair services, as well as long-term paper and microfilm storage, and retrieval option services. In addition, the company offers business process outsourcing services. Intellinetics, Inc. sells its products to resellers and directly to customers, as well as provides access to its software solutions as a service through the Internet. It serves business and federal, county, and municipal governments, as well as healthcare, K-12 education, public safety, other public sector, risk management, financial services, and others. The company was formerly known as GlobalWise Investments, Inc. and changed its name to Intellinetics, Inc. in September 2014. Intellinetics, Inc. was incorporated in 1996 and is headquartered in Columbus, Ohio.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
OTCMKTS:INLX
Fax
N/A
Employees
93
Year Founded
N/A

Sales & Book Value

Annual Sales
$11.46 million
Cash Flow
$0.71 per share
Book Value
$0.96 per share

Profitability

Net Income
$1.36 million
Pretax Margin
4.29%

Debt

Price-To-Earnings

Miscellaneous

Free Float
2,579,000
Market Cap
$14.16 million
Optionable
Not Optionable

Company Calendar

Last Earnings
3/24/2022
Today
5/27/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.35 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -













Intellinetics (OTCMKTS:INLX) Frequently Asked Questions

How were Intellinetics' earnings last quarter?

Intellinetics, Inc. (OTCMKTS:INLX) issued its quarterly earnings results on Thursday, March, 24th. The company reported $0.01 EPS for the quarter. The business earned $2.74 million during the quarter, compared to the consensus estimate of $2.90 million. Intellinetics had a net margin of 4.28% and a trailing twelve-month return on equity of 19.20%.
View Intellinetics' earnings history
.

Who are Intellinetics' key executives?
Intellinetics' management team includes the following people:
  • Mr. James F. DeSocio, Pres, CEO & Director (Age 67, Pay $261.24k)
  • Mr. Joseph D. Spain, CFO & Treasurer (Age 54, Pay $155.03k)
  • Mr. Matthew L. Chretien, Chief Strategy Officer, CTO, Sec. & Director (Age 54, Pay $181.15k)
What other stocks do shareholders of Intellinetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intellinetics investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Kopin (KOPN), Onconova Therapeutics (ONTX), OPKO Health (OPK), Precipio (PRPO), Selecta Biosciences (SELB), Sierra Oncology (SRRA) and T2 Biosystems (TTOO).

What is Intellinetics' stock symbol?

Intellinetics trades on the OTCMKTS under the ticker symbol "INLX."

How do I buy shares of Intellinetics?

Shares of INLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Intellinetics' stock price today?

One share of INLX stock can currently be purchased for approximately $5.00.

How much money does Intellinetics make?

Intellinetics has a market capitalization of $14.16 million and generates $11.46 million in revenue each year. The company earns $1.36 million in net income (profit) each year or $0.439990 on an earnings per share basis.

How many employees does Intellinetics have?

Intellinetics employs 93 workers across the globe.

What is Intellinetics' official website?

The official website for Intellinetics is www.intellinetics.com.

How can I contact Intellinetics?

Intellinetics' mailing address is 2190 DIVIDEND DRIVE, COLUMBUS OH, 43228. The company can be reached via phone at (614) 921-8170 or via email at [email protected].

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.